ATNM
Price
$1.77
Change
-$0.01 (-0.56%)
Updated
Oct 4, 02:43 PM (EDT)
21 days until earnings call
GBIO
Price
$2.42
Change
+$0.04 (+1.68%)
Updated
Oct 4, 03:26 PM (EDT)
34 days until earnings call
Ad is loading...

ATNM vs GBIO

Header iconATNM vs GBIO Comparison
Open Charts ATNM vs GBIOBanner chart's image
Actinium Pharmaceuticals
Price$1.77
Change-$0.01 (-0.56%)
Volume$100
CapitalizationN/A
Generation Bio
Price$2.42
Change+$0.04 (+1.68%)
Volume$650
CapitalizationN/A
View a ticker or compare two or three
ATNM vs GBIO Comparison Chart
Loading...
ATNM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
GBIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ATNM vs. GBIO commentary
Oct 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATNM is a Hold and GBIO is a Hold.

COMPARISON
Comparison
Oct 04, 2024
Stock price -- (ATNM: $1.78 vs. GBIO: $2.38)
Brand notoriety: ATNM and GBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATNM: 31% vs. GBIO: 160%
Market capitalization -- ATNM: $56.08M vs. GBIO: $162.18M
ATNM [@Biotechnology] is valued at $56.08M. GBIO’s [@Biotechnology] market capitalization is $162.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATNM’s FA Score shows that 0 FA rating(s) are green whileGBIO’s FA Score has 0 green FA rating(s).

  • ATNM’s FA Score: 0 green, 5 red.
  • GBIO’s FA Score: 0 green, 5 red.
According to our system of comparison, GBIO is a better buy in the long-term than ATNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATNM’s TA Score shows that 3 TA indicator(s) are bullish while GBIO’s TA Score has 2 bullish TA indicator(s).

  • ATNM’s TA Score: 3 bullish, 3 bearish.
  • GBIO’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, ATNM is a better buy in the short-term than GBIO.

Price Growth

ATNM (@Biotechnology) experienced а -0.56% price change this week, while GBIO (@Biotechnology) price change was +2.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.51%. For the same industry, the average monthly price growth was +3.11%, and the average quarterly price growth was -5.53%.

Reported Earning Dates

ATNM is expected to report earnings on Oct 25, 2024.

GBIO is expected to report earnings on Nov 07, 2024.

Industries' Descriptions

@Biotechnology (+3.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GBIO($162M) has a higher market cap than ATNM($56.1M). GBIO YTD gains are higher at: 44.242 vs. ATNM (-64.961). ATNM has higher annual earnings (EBITDA): -45.91M vs. GBIO (-107.1M). GBIO has more cash in the bank: 217M vs. ATNM (86M). ATNM has less debt than GBIO: ATNM (1.85M) vs GBIO (94M). GBIO has higher revenues than ATNM: GBIO (13.2M) vs ATNM (81K).
ATNMGBIOATNM / GBIO
Capitalization56.1M162M35%
EBITDA-45.91M-107.1M43%
Gain YTD-64.96144.242-147%
P/E RatioN/AN/A-
Revenue81K13.2M1%
Total Cash86M217M40%
Total Debt1.85M94M2%
FUNDAMENTALS RATINGS
ATNM: Fundamental Ratings
ATNM
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATNMGBIO
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 5 days ago
85%
Declines
ODDS (%)
Bearish Trend 9 days ago
86%
Bearish Trend 9 days ago
88%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
ATNM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
GBIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TCMD14.470.23
+1.62%
Tactile Systems Technology
BCC138.29-1.24
-0.89%
Boise Cascade Company
GD299.61-4.31
-1.42%
General Dynamics Corp
AHT0.73-0.01
-1.54%
Ashford Hospitality Trust
AVDL12.81-0.25
-1.91%
Avadel Pharmaceuticals plc

ATNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATNM has been loosely correlated with LOGC. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ATNM jumps, then LOGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATNM
1D Price
Change %
ATNM100%
-6.32%
LOGC - ATNM
43%
Loosely correlated
+2.29%
GBIO - ATNM
39%
Loosely correlated
-5.18%
XNCR - ATNM
38%
Loosely correlated
+0.10%
VYGR - ATNM
36%
Loosely correlated
+2.92%
NTLA - ATNM
36%
Loosely correlated
-4.85%
More

GBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GBIO has been loosely correlated with BEAM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if GBIO jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GBIO
1D Price
Change %
GBIO100%
-5.18%
BEAM - GBIO
47%
Loosely correlated
-2.38%
TECH - GBIO
46%
Loosely correlated
-4.43%
NTLA - GBIO
45%
Loosely correlated
-4.85%
EDIT - GBIO
44%
Loosely correlated
-0.62%
ABOS - GBIO
42%
Loosely correlated
-4.40%
More